Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019

Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019

About PTSD

PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of the gender; its symptoms can develop immediately after a traumatic event or during the course of time. Its symptoms normally include re-experience of the traumatic event, avoidance of the incidents, and abnormal mood swings. Treatments for PTSD include psychological counselling, which help in identifying the cause of the condition and providing counselling to come out of the situation. Medications present in the market help in reducing the symptoms during the course of the treatment.

Technavio's analysts forecast the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global PTSD therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic, off-label, and branded therapies used for the treatment of PTSD. This report includes the segmentation of the market based on geography.

Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • GlaxoSmithKline
  • Pfizer
  • Otsuka Pharmaceutical
Other Prominent Vendors
  • Azevan Pharmaceuticals
  • Baylor Research Institute
  • Eli Lilly
  • Forest Laboratories
  • H. Lundbeck
  • Humanetics Pharmaceuticals
  • Marinus Pharmaceuticals
  • Nanotherapeutics
  • Neurocrine Biosciences
  • Novartis Pharmaceuticals
  • Synchroneuron
  • Tonix Pharmaceuticals
Market Driver
  • Growing Number of Accidents and Violence Worldwide
  • For a full, detailed list, view our report
Market Challenge
  • Unavailability of Standard Diagnostic Methods
  • For a full, detailed list, view our report
Market Trend
  • Rise in Public Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Product Profiles
    • Paxil/Seroxat
    • Zoloft
  • Introduction
  • PTSD Overview
    • Understanding the Disorder
    • Etiology and Pathogenesis
      • Table Events Leading to PTSD
    • Signs and Symptoms
      • Re-experiencing Symptoms
      • Avoidance Symptoms
      • Arousal Symptoms
    • Diagnosis
    • Management
      • Table Treatment Options for PTSD
      • Psychotherapy
      • Pharmacotherapy
    • Self-Help Treatment of PTSD
    • Epidemiology
      • Table Prevalence of PTSD among Women in US
      • Table Global Prevalence of PTSD by Gender
    • Economic Burden
  • Pipeline Analysis
    • Table Pipeline Portfolio of PTSD Drugs
    • Information on Pipeline Candidates
      • Brexpiprazole
      • Iloperidone
      • NBI-77860/GSK-561679
      • At-Ease
      • PRX-3140
      • SNC-102
      • TNX-102 SL
      • Ganaxolone
      • SRX251 and SRX246
      • Doxazosin
      • pep-EphrinA4
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global PTSD Therapeutics Market 2014-2019 ($ millions)
    • Five Forces Analysis
  • Market Segmentation by Class of Drug
    • Table Segmentation of Global PTSD Therapeutics Market by Class of Drug
    • Antidepressant Drugs
      • SSRIs
      • SNRIs
      • Tricyclic Antidepressants
      • MAO Inhibitors
    • Anti-anxiety Drugs
      • Benzodiazepines
      • Beta-blockers
    • Others
      • Atypical Antipsychotics
      • Anticonvulsants
      • Alpha-1 Receptor Antagonists
      • Alpha-2 Adrenergic Agonists
  • Geographical Segmentation
    • Table Segmentation of Global PTSD Therapeutics Market by Region 2014
  • Buying Criteria
  • Market Growth Drivers
    • Table Major Drivers of Global PTSD Therapeutics Market
  • Drivers and Their Impact
  • Market Challenges
    • Table Major Challenges in Global PTSD Therapeutics Market
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Major Trends in Global PTSD Therapeutics Market
  • Trends and Their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Analysis 2014
      • Table Global PTSD Therapeutics Market Analysis 2014
      • Pfizer
        • Table Pfizer: YoY Growth and Revenue of Zoloft 2010-2014 ($ millions)
        • Table Pfizer: Revenue of Zoloft by Region 2010-2014 ($ millions)
      • GlaxoSmithKline
        • Table GlaxoSmithKline: YoY Growth and Revenue of Paxil 2010-2014 ($ millions)
        • Table GlaxoSmithKline: Revenue of Paxil by Region 2010-2014 ($ millions)
      • Otsuka Pharmaceutical
    • Other and Future Prominent Vendors
  • Global PTSD Therapeutics Market: Key Takeaways
    • Table Global PTSD Therapeutics Market: Key Takeaways
  • Key Vendor Analysis
    • GlaxoSmithKline
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 ($ billions)
      • Geographical Segmentation by Revenue 2014
        • Table GlaxoSmithKline: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Otsuka Pharmaceutical
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Otsuka Pharmaceutical: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Otsuka Pharmaceutical: Business Segmentation by Revenue 2013 and 2014 ($ millions)
      • Geographical Segmentation by Revenue 2014
        • Table Otsuka Pharmaceutical: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Pfizer
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table Pfizer: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
      • Geographical Segmentation by Revenue 2014
        • Table Pfizer: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in This Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook